© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 19.18K shares valued at $3.49K. A 0.05% stake in NLS Pharmaceutics AG is owned by the company. XTX TOPCO LTD owns 25.59K shares valued at $4.65K, which translates its holding of 0.07% of the stake in the company.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NLSP shares is N/A, representing N/A of the company's common stock.
WELLS FARGO & COMPANY/MN, in the last quarter, reduced its stake in NLSP by -100% restricting it's holding to 0 shares of worth nearly N/A. RENAISSANCE TECHNOLOGIES LLC also lessened -39.92% of the NLSP shares from its portfolio, reducing its holding to 12.68 thousand shares of worth $7.00K. J. GOLDMAN & CO LP also shunned NLSP shares holding by -100% last quarter which brought its holding to 0 shares worth N/A.
As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in NLSP by 100% in the last quarter. The institutional holder raised its holding to 19.18 thousand shares having worth more than $3.49K. XTX TOPCO LTD also added 100% more shares of NLSP to its portfolio, raising its holding to 25.59 thousand shares of worth $4.65K. RENAISSANCE TECHNOLOGIES LLC also increased its NLSP shares holding by 1,316.56% which brought its holding to 179.58 thousand shares worth $32.00K.
The insider with the most stakes in NLSP is N/A , N/A at the company. Additionally, NLSP stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own N/A percent of NLS Pharmaceutics AG's stock. Within the last six months, there have been 0 transaction(s) in which NLSP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which NLS Pharmaceutics AG insiders have bought stock, totalling 0 shares
Around 0 NLS Pharmaceutics AG shares are held by insiders, which represents about N/A of NLSP stock.
NLSP N/A, N/A holds the largest portfolio of the company's shares. NLSP shares owned by N/A total nearly N/A.
CITADEL ADVISORS LLC is the largest institutional owner in NLSP which holds 19.18 thousand shares worth $3.49K or 0.05% of the total NLSP shares outstanding followed by XTX TOPCO LTD with ownership of 25.59 thousand shares representing 0.07% of the NLSP ownership. RENAISSANCE TECHNOLOGIES LLC is the third largest stakeholder with 179.58 thousand shares or 0.47% of the ownership worth more than $32.00K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NLSP is concerned, it is a stock which is not optionable.
Number of NLSP shares short is 31.25K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 1.17M shares of NLSP are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NLSP has 527.31K shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NLSP is 3.46.